The new study looked at over 730,000 people who were taking medicine for high blood pressure. The researchers followed them ...

High blood pressure, also known as hypertension, is a serious health issue that affects people all over the world. If it’s ...

Patients taking a common diuretic to help lower blood pressure may be better off with a similarly effective but safer one, a new study suggests. Current guidelines recommend the drug chlorthalidone, ...

CHICAGO, IL—Chlorthalidone does not reduce major adverse cardiovascular events compared hydrochlorothiazide in older, predominantly male military veterans with hypertension, according to the ...

Evidence suggests that chlorthalidone may be superior to hydrochlorothiazide (HCTZ) for treating hypertension, but new findings show that chlorthalidone use in older adults is associated with a ...

The guideline-recommended diuretic chlorthalidone for lowering blood pressure was found to cause more serious side effects than hydrochlorothiazide, a similarly effective diuretic, according to a new ...

Chlorthalidone does not differ significantly in kidney outcomes from hydrochlorothiazide, but it is associated with a higher risk for hypokalemia. Chlorthalidone is not superior to hydrochlorothiazide ...

Chlorthalidone, the guideline-recommended diuretic for lowering blood pressure, causes more serious side effects than hydrochlorothiazide, a similarly effective diuretic, according to a new study led ...

New data continue to emerge from subgroup analyses of The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). [1] The analyses particularly address the concerns about ...

BOSTON -- In people with hypertension, a history of kidney stones may inform the choice of diuretic for stone prevention, according to a secondary analysis of the Diuretic Comparison Project. Among ...

Q: I started taking a diuretic because my blood pressure was still too high. Should I take a potassium supplement? A: The answer is not straightforward. It depends upon a few important factors: which ...

May 24, 2011 (New York, New York) — The use of the combination therapy azilsartan medoxomil (Edarbi, Takeda Pharmaceuticals) and chlorthalidone resulted in a more effective reduction in systolic blood ...